NCT06345911

Brief Summary

The study was designed as a randomized controlled experimental research with the purpose of determining the effect of distraction by using vacutainers of three different animal characters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2022

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

March 28, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 3, 2024

Completed
Last Updated

April 3, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

March 28, 2024

Last Update Submit

March 28, 2024

Conditions

Keywords

BloodlettingAnimal VacutainerProcedural PainFearDistraction

Outcome Measures

Primary Outcomes (2)

  • Children's Fear Scale

    CFS is used for measuring the child's anxiety level. CFS is a scale which makes an evaluation from 0 to 4 consisting of five facial expressions drawn to show expressions that vary from neutral expression (0=no anxiety) to scared face (4=severe anxiety).

    Through painful procedure completion, an average of 10 minutes

  • Wong-Baker FACES Pain Rating Scale

    In the study, pain level evaluations, the children's self-evaluations, parents' evaluations and the researcher's evaluations were carried out using the WB-FACES scale. This scale was developed by Donna Wong and Connie Morain Baker in 1988. The scale is graded between 0-10 points. A smiling face on the far left symbolizes "no pain" (0 very happy/no pain) and the pain increases from left to right. On the other hand, a crying face on the far right symbolizes "unbearable pain" (10 'hurts worst'). As the numbers increase in this scoring system, facial expressions also change referring to an increase in pain levels.

    Through painful procedure completion, an average of 10 minutes.

Study Arms (2)

Experimental group

EXPERIMENTAL

The animal characters were shown to the child before the bloodletting procedure. The child was asked to choose one of them and the one chosen by the child was attached to the vacutainer.

Behavioral: Experimental group

Control group

NO INTERVENTION

The child was subjected to routine bloodletting intervention with the vacutainer.

Interventions

The animal characters were shown to the child before the bloodletting procedure. The child was asked to choose one of them and the one chosen by the child was attached to the vacutainer. The child and their parents were taken to the blood collection room. During the bloodletting procedure, the child was asked to focus on the animal character they had chosen.

Experimental group

Eligibility Criteria

Age4 Years - 7 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The child was selected by simple randomization.
  • The child was between 4-7 years old.
  • The child and parent were informed and their written consent was obtained prior to the procedure.
  • The bloodletting procedure was performed by the same nurse.
  • The child was given standard information before the bloodletting procedure.
  • The needle used for the bloodletting procedure was of the same thickness.
  • The child could evaluate the pain and fear scales.

You may not qualify if:

  • The child was excluded from the study if they had the following criteria;
  • The child had infection, skin integrity disturbance, and rash in the area where the procedure would be performed.
  • The child had nerve damage in the previously treated area.
  • The child's health status was critical and unstable.
  • The child had developmental retardation that prevents them from responding to pain and fear scales.
  • The child had taken any analgesic in the last 6 hours before the bloodletting procedure.
  • The child did not want to participate.
  • The child did not meet the selection criteria for the experimental and control groups.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karaman Education and Research Hospital

Karaman, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, ProceduralAcute PainAnxiety Disorders

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Selda Ateş Beşirik, PhD.

    Burdur Mehmet Akif Ersoy University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 28, 2024

First Posted

April 3, 2024

Study Start

December 1, 2021

Primary Completion

February 25, 2022

Study Completion

March 30, 2022

Last Updated

April 3, 2024

Record last verified: 2024-03

Locations